Niravi 24 Hours Lidocaine 4 % Patch
NDC Package 73638-901-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Niravi 24 Hours Lidocaine 4 % Patch is a . Marketed by Sparsha Pharma Usa, Inc., this product is identified by NDC 73638-901 and is authorized under FDA application M17.

Identification & Billing

NDC Package Code
73638-901-01
Package Description
6 PATCH in 1 CARTON / 1 g in 1 PATCH
Product Code
73638-901
11-Digit Billing Format
73638090101

Clinical Specifications

Proprietary Name
Niravi 24 Hours Lidocaine 4 % Patch
Dosage Form
-

Regulatory & Marketing

Labeler Name
Sparsha Pharma Usa, Inc.
FDA Application #
M17
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
06-30-2021
End Marketing Date
08-31-2025
Listing Expiration
08-31-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73638-901-01 identifies a specific commercial package of 6 patch in 1 carton / 1 g in 1 patch of Niravi 24 Hours Lidocaine 4 % Patch, labeled by Sparsha Pharma Usa, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sparsha Pharma Usa, Inc. on June 30, 2021. The current certification is valid through August 31, 2025.

How is this Sparsha Pharma Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73638090101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73638-901-01
11-Digit CMS (5-4-2)
73638-0901-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.